Edivoxetine Hydrochloride and its Impurities

Edivoxetine Hydrochloride is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. Reference standards of Edivoxetine Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.